Longevity Health Holdings, Inc. Common Stock
XAGE
XAGE was delisted on the 11th of September, 2025.
38 hedge funds and large institutions have $113M invested in Longevity Health Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 6 closing their positions.
0.31% less ownership
Funds ownership: 2.7% → 2.39% (-0.31%)
5% less funds holding
Funds holding: 40 → 38 (-2)
10% less capital invested
Capital invested by funds: $125M → $113M (-$12.2M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
+$2.39M |
| 2 |
ETH
Exos TFP Holdings
New York
|
+$1.01M |
| 3 |
FTCM
Fir Tree Capital Management
New York
|
+$876K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$51.1K |
| 5 |
DAM
DLD Asset Management
New York
|
+$49.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$14.5M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$1.23M |
| 3 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$1.09M |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$771K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$323K |
XAGE Hedge Fund Activity: Q4 2022 in Review
38 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Common Stock (XAGE) for Q4 2022, worth a combined $113M — down 9.7% from $125M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of XAGE and 4 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 3 added.
The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $2.39M. The largest seller was UBS O'Connor, exiting entirely with an estimated $14.5M sold.
- 38 institutional investors held Longevity Health Holdings, Inc. Common Stock (XAGE) as of Q4 2022, down from 40 in Q3 2022.
- Funds reported $113M of Longevity Health Holdings, Inc. Common Stock stock for Q4 2022, down 9.7% quarter-over-quarter.
- 4 funds opened new Longevity Health Holdings, Inc. Common Stock positions in Q4 2022 and 6 closed out, a net change of -2 holders.
- The largest Longevity Health Holdings, Inc. Common Stock buyer in Q4 2022 was Cantor Fitzgerald, an estimated $2.39M added.
- The largest Longevity Health Holdings, Inc. Common Stock seller in Q4 2022 was UBS O'Connor, an estimated $14.5M sold.
Based on aggregated 13F filings for Q4 2022.